Adverse Event Reporting

VAERS ID 1531412
Gender Male
Age 83
StateCode FR
Pharmaceutical Company MODERNA
Lot Number
Number of vaccinations
Vaccinated 2021-03-30
Onset 2021-04-04
Condition Recovered
Symptoms
  • Viral test
  • Herpes zoster cutaneous disseminated

Current Illness

Preexisting Conditions

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Test Date: 20210413; Test Name: Viral PCR test; Test Result: Positive ; Result Unstructured Data: Positive

Write-up

This regulatory authority case was reported by a physician and describes the occurrence of HERPES ZOSTER CUTANEOUS DISSEMINATED in an 83-year-old male patient who received mRNA-1273 (COVID-19 Vaccine Moderna) for COVID-19 vaccination.
No Medical History information was reported.
On 30-Mar-2021, the patient received dose of mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) 1 dosage form.
On 04-Apr-2021, after starting mRNA-1273 (COVID-19 Vaccine Moderna), the patient experienced HERPES ZOSTER CUTANEOUS DISSEMINATED (seriousness criterion medically significant).
On 02-May-2021, HERPES ZOSTER CUTANEOUS DISSEMINATED (had resolved.
DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Viral test: positive (Positive) Positive.
For mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular), the reporter considered HERPES ZOSTER CUTANEOUS DISSEMINATED to be possibly related.
Concomitant product was not provided by the reporter.
Treatment information was not provided.
Company comments:Based on the current available information which includes a temporal association between the use of the product and onset of the event, a causal relationship cannot be excluded.
Some vaccines have been known to exacerbate latent herpes zoster.
; Sender's Comments: Based on the current available information which includes a temporal association between the use of the product and onset of the event, , a causal relationship cannot be excluded.
Some vaccines have been known to exacerbate latent herpes zoster.